America’s biopharmaceutical companies are working to discover and develop new medicines for patients. These efforts are paying off with remarkable gains in the fight against disease.
In an era of rapid scientific advancement, America’s biopharmaceutical researchers are working tirelessly to translate new findings into innovative treatments for patients.
When patients get better, the positive effects radiate out beyond families and friends to strengthen the entire U.S. health system.
America’s biopharmaceutical research companies are making important economic contributions in communities across the U.S.
Click to watch the live stream and join the conversation. #PhRMA16
View the latest news, blog posts, and opinion pieces from PhRMA and From Hope to Cures
Biopharmaceutical research companies are developing 171 medicines to treat diabetes and related conditions. Learn more at #Hope2Cures
PhRMA Executive VP and Chief Medical Officer William Chin M.D. talks about new and exciting therapies for diabetes.
"Being a part of the biopharmaceutical research and development (R&D) process has been incredibly gratifying because our work directly improves people’s lives."